Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH ESKD

Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH ESKD explained in plain language.

Never miss a new study

Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH ESKD trials appear

Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH ESKD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to protect failing hearts in dialysis patients

Disease control Recruiting now

This study is testing an investigational drug called CSL300 (clazakizumab) to see if it can lower the risk of heart attacks and death in people with end-stage kidney disease who are on dialysis. The trial will enroll over 2,300 adults who have both kidney failure and either heart…

Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH ESKD

Phase: PHASE2, PHASE3 • Sponsor: CSL Behring • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC